Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis

Shane T Killarney1, Rachel Washart1, Ryan S Soderquist1

  • 1Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.

Nature Communications
|March 15, 2023
PubMed

Insights

During apoptosis, mitochondrial RNA (mtRNA) is released into the cytoplasm. Executioner caspases-3 and -7 normally prevent this mtRNA from causing inflammation, but inhibiting them can boost anti-tumor immunity.

Area of Science:

  • Cell Biology
  • Immunology
  • Cancer Research

Background:

  • Mitochondrial outer membrane permeabilization (MOMP) during apoptosis releases macromolecules.
  • The fate and role of mitochondrial RNA (mtRNA) during apoptosis remain unclear.

Purpose of the Study:

  • To investigate the release and function of mtRNA during apoptosis.
  • To determine the role of executioner caspases in regulating mtRNA-mediated signaling.
  • To explore the therapeutic potential of modulating this pathway in cancer.

Main Methods:

  • Investigated mtRNA release during MOMP.
  • Utilized genetic and pharmacological inhibition of caspases-3 and -7 (casp3/7).
  • Assessed activation of the MDA5/MAVS/IRF3 pathway and Type I interferon (IFN) signaling.
  • Evaluated anti-tumor immunity in immunologically cold cancer models.

Main Results:

  • MOMP leads to the cytoplasmic release of mtRNA.
  • Casp3/7 inhibit inflammatory signaling triggered by cytoplasmic mtRNA.
  • Inhibition of casp3/7 activates the MDA5/MAVS/IRF3 pathway, driving Type I IFN signaling.
  • This pathway enhances CD8+ T-cell-dependent anti-tumor immunity and overcomes anti-PD1 resistance.

Conclusions:

  • Caspases-3 and -7 play a crucial role in suppressing inflammation from released mtRNA.
  • Modulating casp3/7 activity can enhance the immunogenicity of chemotherapy-induced apoptosis.
  • Targeting this pathway offers a strategy to improve cancer immunotherapy outcomes.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.7K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.5K